08:55 AM EDT, 08/26/2025 (MT Newswires) -- Health care stocks were steady premarket Tuesday, with The Health Care Select Sector SPDR Fund (XLV) marginally lower and the iShares Biotechnology ETF (IBB) unchanged.

Eli Lilly ( LLY ) shares were up more than 3% after the company said a phase 3 trial evaluating the investigational drug orforglipron in adults with obesity, or overweight, and type 2 diabetes met its primary and secondary endpoints.